相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Does adherence to lipid-lowering medications improve cancer survival? A nationwide study of breast and colorectal cancer, and melanoma
Jia-Li Feng et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2021)
MITOCHONDRIAL CHOLESTEROL AND CANCER
Carmen Garcia-Ruiz et al.
SEMINARS IN CANCER BIOLOGY (2021)
CD36-the Achilles' heel of Treg cells
Brendan L. Horton et al.
NATURE IMMUNOLOGY (2020)
Statin and Cancer Mortality and Survival: An Umbrella Systematic Review and Meta-Analysis
Gwang Hun Jeong et al.
JOURNAL OF CLINICAL MEDICINE (2020)
Pyruvate Kinase M2 and Cancer: The Role of PKM2 in Promoting Tumorigenesis
Kulsoom Zahra et al.
FRONTIERS IN ONCOLOGY (2020)
Statin use, HMGCR expression, and breast cancer survival - The Malmo Diet and Cancer Study
Olof Bjarnadottir et al.
SCIENTIFIC REPORTS (2020)
Cholesterol and beyond - The role of the mevalonate pathway in cancer biology
Andy Goebel et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2020)
Genetic Alterations in the PI3K/AKT Pathway and Baseline AKT Activity Define AKT Inhibitor Sensitivity in Breast Cancer Patient-derived Xenografts
Albert Gris-Oliver et al.
CLINICAL CANCER RESEARCH (2020)
Statin Use Decreases the Incidence of Hepatocellular Carcinoma: An Updated Meta-Analysis
Antonio Facciorusso et al.
CANCERS (2020)
The Pivotal Role of the Dysregulation of Cholesterol Homeostasis in Cancer: Implications for Therapeutic Targets
Etienne Ho Kit Mok et al.
CANCERS (2020)
Targeting the Microenvironment in MDS: The Final Frontier
Patric Teodorescu et al.
FRONTIERS IN PHARMACOLOGY (2020)
Beyond lipid-lowering: role of statins in endometrial cancer
Abdul Muzhill Hannaan Abdul Hafizz et al.
MOLECULAR BIOLOGY REPORTS (2020)
GLUT1 inhibition blocks growth of RB1-positive triple negative breast cancer
Qin Wu et al.
NATURE COMMUNICATIONS (2020)
Cholesterol metabolism: At the cross road between cancer cells and immune environment
Joanna Kopecka et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2020)
Cholesterol metabolism in cancer: mechanisms and therapeutic opportunities
Binlu Huang et al.
NATURE METABOLISM (2020)
Role of de novo cholesterol synthesis enzymes in cancer
Jie Yang et al.
JOURNAL OF CANCER (2020)
Reduced Protumorigenic Tumor-Associated Macrophages With Statin Use in Premalignant Human Lung Adenocarcinoma
Esraa Al Dujaily et al.
JNCI CANCER SPECTRUM (2020)
Nuclear Receptors: Recent Drug Discovery for Cancer Therapies
Linjie Zhao et al.
ENDOCRINE REVIEWS (2019)
LXR Signaling Regulates Macrophage Survival and Inflammation in Response to Ionizing Radiation
Carlos Tabraue et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2019)
Induction of 3-hydroxy-3-methylglutaryl-CoA reductase mediates statin resistance in breast cancer cells
Andy Goebel et al.
CELL DEATH & DISEASE (2019)
An actionable sterol-regulated feedback loop modulates statin sensitivity in prostate cancer
Joseph Longo et al.
MOLECULAR METABOLISM (2019)
The Roles of Cholesterol and Its Metabolites in Normal and Malignant Hematopoiesis
Hideyuki Oguro
FRONTIERS IN ENDOCRINOLOGY (2019)
Lipid-dependent Akt-ivity: where, when, and how
Katharina M. Siess et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2019)
JAK/STAT inhibition in macrophages promotes therapeutic resistance by inducing expression of protumorigenic factors
Emily A. Irey et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Increased Cholesterol Biosynthesis Is a Key Characteristic of Breast Cancer Stem Cells Influencing Patient Outcome
Sidse Ehmsen et al.
CELL REPORTS (2019)
Moving Myeloid Leukemia Drug Discovery Into the Third Dimension
Donna M. Cartledge Wolf et al.
FRONTIERS IN PEDIATRICS (2019)
Effect of Statin on Cancer Incidence: An Umbrella Systematic Review and Meta-Analysis
Gwang Hun Jeong et al.
JOURNAL OF CLINICAL MEDICINE (2019)
Effects of simvastatin on matrix metalloproteinase regulation in IL-1β-induced SW1353 cells
Berivan Cecen et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2019)
Statin use and the risk of colorectal cancer in a population-based electronic health records study
Gemma Ibanez-Sanz et al.
SCIENTIFIC REPORTS (2019)
Tumor-Associated Macrophages in Hematologic Malignancies: New Insights and Targeted Therapies
Amy J. Petty et al.
CELLS (2019)
Statin use and breast cancer survival - a Swedish nationwide study
Signe Borgquist et al.
BMC CANCER (2019)
Crosstalk between Estrogen Signaling and Breast Cancer Metabolism
Eylem Kulkoyluoglu-Cotul et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2019)
The Potential of Isoprenoids in Adjuvant Cancer Therapy to Reduce Adverse Effects of Statins
Huanbiao Mo et al.
FRONTIERS IN PHARMACOLOGY (2019)
Cholesterol and Its Metabolites in Tumor Growth: Therapeutic Potential of Statins in Cancer Treatment
Adele Chimento et al.
FRONTIERS IN ENDOCRINOLOGY (2019)
JAK-STAT Signaling: A Double-Edged Sword of Immune Regulation and Cancer Progression
Katie L. Owen et al.
CANCERS (2019)
Therapeutically exploiting STAT3 activity in cancer - using tissue repair as a road map
Jennifer Huynh et al.
NATURE REVIEWS CANCER (2019)
Regulatory mechanisms of hypoxia-inducible factor 1 activity: Two decades of knowledge
Sho Koyasu et al.
CANCER SCIENCE (2018)
Metabolic Induction of Trained Immunity through the Mevalonate Pathway
Siroon Bekkering et al.
CELL (2018)
SCAP/SREBPs are Central Players in Lipid Metabolism and Novel Meta-bolic Targets in Cancer Therapy
Xiang Cheng et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2018)
Simvastatin exerts anticancer effects in osteosarcoma cell lines via geranylgeranylation and c-Jun activation
Shinwan Kany et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2018)
New links between lipid accumulation and cancer progression
Joseph T. Nickels
JOURNAL OF BIOLOGICAL CHEMISTRY (2018)
Targeting the Mevalonate Pathway Suppresses VHL-Deficient CC-RCC through an HIF-Dependent Mechanism
Jordan M. Thompson et al.
MOLECULAR CANCER THERAPEUTICS (2018)
Targeting Mevalonate Pathway in Cancer Treatment: Repurposing of Statins
Federica Iannelli et al.
RECENT PATENTS ON ANTI-CANCER DRUG DISCOVERY (2018)
Interacting Cancer Machineries: Cell Signaling, Lipid Metabolism, and Epigenetics
Thomas W. Grunt
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2018)
STAT3-activated CD36 facilitates fatty acid uptake in chronic lymphocytic leukemia cells
Uri Rozovski et al.
Oncotarget (2018)
Simvastatin Therapy for Drug Repositioning to Reduce the Risk of Prostate Cancer Mortality in Patients With Hyperlipidemia
Yu-An Chen et al.
FRONTIERS IN PHARMACOLOGY (2018)
The Effects of Cholesterol-Derived Oncometabolites on Nuclear Receptor Function in Cancer
Sandrine Silvente-Poirot et al.
CANCER RESEARCH (2018)
Cholesterol as an Endogenous ERRα Agonist: A New Perspective to Cancer Treatment
Ivan Casaburi et al.
FRONTIERS IN ENDOCRINOLOGY (2018)
Mevalonate Metabolism in Cancer Stemness and Trained Immunity
Georg Gruenbacher et al.
FRONTIERS IN ONCOLOGY (2018)
Statins attenuate outgrowth of breast cancer metastases
Colin H. Beckwitt et al.
BRITISH JOURNAL OF CANCER (2018)
The critical role of AMPK in driving Akt activation under stress, tumorigenesis and drug resistance
Fei Han et al.
NATURE COMMUNICATIONS (2018)
Combination statin and chemotherapy inhibits proliferation and cytotoxicity of an aggressive natural killer cell leukemia
Austin B. Henslee et al.
BIOMARKER RESEARCH (2018)
Targeting mutant p53 for efficient cancer therapy
Vladimir J. N. Bykov et al.
NATURE REVIEWS CANCER (2018)
Simvastatin-Induced Apoptosis in Osteosarcoma Cells: A Key Role of RhoA-AMPK/p38 MAPK Signaling in Antitumor Activity
Walied A. Kamel et al.
MOLECULAR CANCER THERAPEUTICS (2017)
Targeting metastasis-initiating cells through the fatty acid receptor CD36
Gloria Pascual et al.
NATURE (2017)
The current evidence on statin use and prostate cancer prevention: are we there yet?
Mahmoud A. Alfaqih et al.
NATURE REVIEWS UROLOGY (2017)
Zoledronic acid impairs stromal reactivity by inhibiting M2-macrophages polarization and prostate cancer-associated fibroblasts
Giuseppina Comito et al.
ONCOTARGET (2017)
New horizons in hypoxia signaling pathways
Christopher W. Pugh et al.
EXPERIMENTAL CELL RESEARCH (2017)
Effects of statins on cancer mortality and progression: A systematic review and meta-analysis of 95 cohorts including 1,111,407 individuals
Zubing Mei et al.
INTERNATIONAL JOURNAL OF CANCER (2017)
Hypoxia-inducible factor 1α activates insulin-induced gene 2 (Insig-2) transcription for degradation of 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase in the liver
Seonghwan Hwang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2017)
Tumour-associated macrophages as treatment targets in oncology
Alberto Mantovani et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2017)
SREBP-regulated lipid metabolism: convergent physiology - divergent pathophysiology
Hitoshi Shimano et al.
NATURE REVIEWS ENDOCRINOLOGY (2017)
The mystery of membrane organization: composition, regulation and roles of lipid rafts
Erdinc Sezgin et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2017)
Mechanobiology of YAP and TAZ in physiology and disease
Tito Panciera et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2017)
The RB-IL-6 axis controls self-renewal and endocrine therapy resistance by fine-tuning mitochondrial activity
S. Kitajima et al.
ONCOGENE (2017)
Simvastatin-induced cell cycle arrest through inhibition of STAT3/SKP2 axis and activation of AMPK to promote p27 and p21 accumulation in hepatocellular carcinoma cells
Sin-Ting Wang et al.
CELL DEATH & DISEASE (2017)
Stromal regulation of prostate cancer cell growth by mevalonate pathway enzymes HMGCS1 and HMGCR
Shingo Ashida et al.
ONCOLOGY LETTERS (2017)
The cholesterol metabolite 27 hydroxycholesterol facilitates breast cancer metastasis through its actions on immune cells
Amy E. Baek et al.
NATURE COMMUNICATIONS (2017)
Drug repositioning of mevalonate pathway inhibitors as antitumor agents for ovarian cancer
Yusuke Kobayashi et al.
ONCOTARGET (2017)
Reprogramming of Tumor-Associated Macrophages with Anticancer Therapies: Radiotherapy versus Chemo- and immunotherapies
Geraldine Genard et al.
FRONTIERS IN IMMUNOLOGY (2017)
Mevalonate metabolism governs cancer immune surveillance
Georg Gruenbacher et al.
ONCOIMMUNOLOGY (2017)
PTEN status is a crucial determinant of the functional outcome of combined MEK and mTOR inhibition in cancer
Michele Milella et al.
SCIENTIFIC REPORTS (2017)
Cholesterol Enhances Colorectal Cancer Progression via ROS Elevation and MAPK Signaling Pathway Activation
Caihua Wang et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2017)
Post-transcriptional Regulation of De Novo Lipogenesis by mTORC1-S6K1-SRPK2 Signaling
Gina Lee et al.
CELL (2017)
Hedgehog Signaling: From Basic Biology to Cancer Therapy
Fujia Wu et al.
CELL CHEMICAL BIOLOGY (2017)
Oncogenic PI3K and K-Ras stimulate de novo lipid synthesis through mTORC1 and SREBP
S. J. H. Ricoult et al.
ONCOGENE (2016)
Srebp-1 Interacts with c-Myc to Enhance Somatic Cell Reprogramming
Yi Wu et al.
STEM CELLS (2016)
Oxysterols: Old Tale, New Twists
Winnie Luu et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 56 (2016)
Additive inhibitory effects of simvastatin and enzalutamide on androgen-sensitive LNCaP and VCaP prostate cancer cells
Heimo Syvala et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2016)
Phase I biomarker modulation study of atorvastatin in women at increased risk for breast cancer
Banu K. Arun et al.
BREAST CANCER RESEARCH AND TREATMENT (2016)
The Emerging Hallmarks of Cancer Metabolism
Natalya N. Pavlova et al.
CELL METABOLISM (2016)
Ligand Activation of ERRα by Cholesterol Mediates Statin and Bisphosphonate Effects
Wei Wei et al.
CELL METABOLISM (2016)
The effects of metformin and simvastatin on the growth of LNCaP and RWPE-1 prostate epithelial cell lines
Pasi Pennanen et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2016)
Association Between Statin Use After Diagnosis of Esophageal Cancer and Survival: A Population-Based Cohort Study
Leo Alexandre et al.
GASTROENTEROLOGY (2016)
The Primary Effect on the Proteome of ARID1A-mutated Ovarian Clear Cell Carcinoma is Downregulation of the Mevalonate Pathway at the Post-transcriptional Level
Aaron R. Goldman et al.
MOLECULAR & CELLULAR PROTEOMICS (2016)
Regulating Rho GTPases and their regulators
Richard G. Hodge et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2016)
SREBP-2 promotes stem cell-like properties and metastasis by transcriptional activation of c-Myc in prostate cancer
Xiangyan Li et al.
ONCOTARGET (2016)
Meta-analysis of studies using statins as a reducer for primary liver cancer risk
Guo-Chao Zhong et al.
SCIENTIFIC REPORTS (2016)
SR-BI: Linking Cholesterol and Lipoprotein Metabolism with Breast and Prostate Cancer
Jorge L. Gutierrez-Pajares et al.
FRONTIERS IN PHARMACOLOGY (2016)
Altered metabolite levels in cancer: implications for tumour biology and cancer therapy
Lucas B. Sullivan et al.
NATURE REVIEWS CANCER (2016)
The interplay between cell signalling and the mevalonate pathway in cancer
Peter J. Mullen et al.
NATURE REVIEWS CANCER (2016)
From Krebs to clinic: glutamine metabolism to cancer therapy
Brian J. Altman et al.
NATURE REVIEWS CANCER (2016)
Dose-specific effect of simvastatin on hypoxia-induced HIF-1α and BACE expression in Alzheimer's disease cybrid cells
Jin-Heon Jeong et al.
BMC NEUROLOGY (2015)
Reduced Expression of MYC Increases Longevity and Enhances Healthspan
Jeffrey W. Hofmann et al.
CELL (2015)
Uncoupling Nuclear Receptor LXR and Cholesterol Metabolism in Cancer
Fabiola Bovenga et al.
CELL METABOLISM (2015)
Acetyl Coenzyme A: A Central Metabolite and Second Messenger
Federico Pietrocola et al.
CELL METABOLISM (2015)
MgcRacGAP inhibition stimulates JAK-dependent STAT3 activity
Arjan J. van Adrichem et al.
FEBS LETTERS (2015)
A hostel for the hostile: the bone marrow niche in hematologic neoplasms
Daniela S. Krause et al.
HAEMATOLOGICA (2015)
Statin-induced anti-proliferative effects via cyclin D1 and p27 in a window-of-opportunity breast cancer trial
Maria Feldt et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2015)
Metabolic pathways promoting cancer cell survival and growth
Lindsey K. Boroughs et al.
NATURE CELL BIOLOGY (2015)
Cholesterol uptake disruption, in association with chemotherapy, is a promising combined metabolic therapy for pancreatic adenocarcinoma
Fabienne Guillaumond et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Differential epigenetic reprogramming in response to specific endocrine therapies promotes cholesterol biosynthesis and cellular invasion
Van T. M. Nguyen et al.
NATURE COMMUNICATIONS (2015)
Genome-wide RNAi analysis reveals that simultaneous inhibition of specific mevalonate pathway genes potentiates tumor cell death
Aleksandra A. Pandyra et al.
ONCOTARGET (2015)
Lovastatin overcomes gefitinib resistance through TNF-α signaling in human cholangiocarcinomas with different LKB1 statuses in vitro and in vivo
Sheng-Huei Yang et al.
ONCOTARGET (2015)
A hostel for the hostile: the bone marrow niche in hematologic neoplasms
Daniela S. Krause et al.
HAEMATOLOGICA (2015)
Statins use and the risk of all and subtype hematological malignancies: a meta-analysis of observational studies
Danitza Pradelli et al.
CANCER MEDICINE (2015)
Statin Use at the Time of Initiation of Androgen Deprivation Therapy and Time to Progression in Patients With Hormone-Sensitive Prostate Cancer
Lauren C. Harshman et al.
JAMA ONCOLOGY (2015)
STAT3-mediated metabolic reprograming in cellular transformation and implications for drug resistance
Valeria Poli et al.
FRONTIERS IN ONCOLOGY (2015)
The Hippo pathway in chemotherapeutic drug resistance
Yulei Zhao et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
Targeting liver X receptors in cancer therapeutics
Chin-Yo Lin et al.
NATURE REVIEWS CANCER (2015)
Identifying molecular features that distinguish fluvastatin-sensitive breast tumor cells
Carolyn A. Goard et al.
BREAST CANCER RESEARCH AND TREATMENT (2014)
Comparative safety of cardiovascular medication use and breast cancer outcomes among women with early stage breast cancer
Denise M. Boudreau et al.
BREAST CANCER RESEARCH AND TREATMENT (2014)
Randomized double-blinded, placebo-controlled phase II trial of simvastatin and gemcitabine in advanced pancreatic cancer patients
Jung Yong Hong et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2014)
Simvastatin suppresses head and neck squamous cell carcinoma ex vivo and enhances the cytostatic effects of chemotherapeutics
Matthaeus Stoehr et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2014)
Simvastatin plus capecitabine-cisplatin versus placebo plus capecitabine-cisplatin in patients with previously untreated advanced gastric cancer: A double-blind randomised phase 3 study
Seung Tae Kim et al.
EUROPEAN JOURNAL OF CANCER (2014)
Effect of simvastatin on the resistance to EGFR tyrosine kinase inhibitors in a non-small cell lung cancer with the T790M mutation of EGFR
Ki-Eun Hwang et al.
EXPERIMENTAL CELL RESEARCH (2014)
Statin Use Is Associated With Reduced Risk of Histologic Subtypes of Esophageal Cancer: A Nested Case-Control Analysis
Leo Alexandre et al.
GASTROENTEROLOGY (2014)
Effect of simvastatin plus cetuximab/irinotecan for KRAS mutant colorectal cancer and predictive value of the RAS signature for treatment response to cetuximab
Jeeyun Lee et al.
INVESTIGATIONAL NEW DRUGS (2014)
Hematopoiesis and RAS-driven myeloid leukemia differentially require PI3K isoform p110α
Kira Gritsman et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Simvastatin sensitizes human gastric cancer xenograft in nude mice to capecitabine by suppressing nuclear factor-kappa B-regulated gene products
Kanjoormana A. Manu et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2014)
Fatostatin Displays High Antitumor Activity in Prostate Cancer by Blocking SREBP-Regulated Metabolic Pathways and Androgen Receptor Signaling
Xiangyan Li et al.
MOLECULAR CANCER THERAPEUTICS (2014)
Metabolic control of YAP and TAZ by the mevalonate pathway
Giovanni Sorrentino et al.
NATURE CELL BIOLOGY (2014)
Drugging the undruggable RAS: Mission Possible?
Adrienne D. Cox et al.
NATURE REVIEWS DRUG DISCOVERY (2014)
Making new contacts: the mTOR network in metabolism and signalling crosstalk
Mitsugu Shimobayashi et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2014)
Statin Use Is Associated with Reduced Risk of Haematological Malignancies: Evidence from a Meta-Analysis
Xiao Yi et al.
PLOS ONE (2014)
Statins: protectors or pretenders in prostate cancer?
Hyeongsun Moon et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2014)
Statin-induced mevalonate pathway inhibition attenuates the growth of mesenchymal-like cancer cells that lack functional E-cadherin mediated cell cohesion
Katsuhiko Warita et al.
SCIENTIFIC REPORTS (2014)
Revisiting STAT3 signalling in cancer: new and unexpected biological functions
Hua Yu et al.
NATURE REVIEWS CANCER (2014)
Synergistic killing effect of imatinib and simvastatin on imatinib-resistant chronic myelogenous leukemia cells
Bora Oh et al.
ANTI-CANCER DRUGS (2013)
Targeting HMG-CoA reductase with statins in a window-of-opportunity breast cancer trial
Olof Bjarnadottir et al.
BREAST CANCER RESEARCH AND TREATMENT (2013)
Pharmacokinetics of high-dose simvastatin in refractory and relapsed chronic lymphocytic leukemia patients
Tamer A. Ahmed et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2013)
Gadd45a Suppresses Tumor Angiogenesis via Inhibition of the mTOR/STAT3 Protein Pathway
Fang Yang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Mitochondrial Localized Stat3 Promotes Breast Cancer Growth via Phosphorylation of Serine 727
Qifang Zhang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Development of PI3K inhibitors: lessons learned from early clinical trials
Jordi Rodon et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2013)
Chronic hypoxia induces androgen-independent and invasive behavior in LNCaP human prostate cancer cells
Mutsushi Yamasaki et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2013)
Atorvastatin overcomes gefitinib resistance in KRAS mutant human non-small cell lung carcinoma cells
J. Chen et al.
CELL DEATH & DISEASE (2013)
Statin inhibits hypoxia-induced endothelin-1 via accelerated degradation of HIF-1 in vascular smooth muscle cells
Tetsuya Hisada et al.
CARDIOVASCULAR RESEARCH (2012)
Mutant p53 Disrupts Mammary Tissue Architecture via the Mevalonate Pathway
William A. Freed-Pastor et al.
CELL (2012)
A novel miR-155/miR-143 cascade controls glycolysis by regulating hexokinase 2 in breast cancer cells
Shuai Jiang et al.
EMBO JOURNAL (2012)
Targeting tumor cell metabolism with statins
J. W. Clendening et al.
ONCOGENE (2012)
Consumption of oxygen: a mitochondrial-generated progression signal of advanced cancer
C. C. Cook et al.
CELL DEATH & DISEASE (2012)
Pharmacological Actions of Statins: A Critical Appraisal in the Management of Cancer
Patrizia Gazzerro et al.
PHARMACOLOGICAL REVIEWS (2012)
Thalidomide, dexamethasone and lovastatin with autologous stem cell transplantation as a salvage immunomodulatory therapy in patients with relapsed and refractory multiple myeloma
Marek Hus et al.
ANNALS OF HEMATOLOGY (2011)
MYC Phosphorylation, Activation, and Tumorigenic Potential in Hepatocellular Carcinoma Are Regulated by HMG-CoA Reductase
Zhongwei Cao et al.
CANCER RESEARCH (2011)
AMPK Phosphorylates and Inhibits SREBP Activity to Attenuate Hepatic Steatosis and Atherosclerosis in Diet-Induced Insulin-Resistant Mice
Yu Li et al.
CELL METABOLISM (2011)
The R(h)oads to Stat3: Stat3 activation by the Rho GTPases
Leda Raptis et al.
EXPERIMENTAL CELL RESEARCH (2011)
Mitochondrial-targeted Signal Transducer and Activator of Transcription 3 (STAT3) Protects against Ischemia-induced Changes in the Electron Transport Chain and the Generation of Reactive Oxygen Species
Karol Szczepanek et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Anticancer Efficacy of Simvastatin on Prostate Cancer Cells and Tumor Xenografts Is Associated with Inhibition of Akt and Reduced Prostate-Specific Antigen Expression
Samith T. Kochuparambil et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2011)
Statin Prescriptions and Breast Cancer Recurrence Risk: A Danish Nationwide Prospective Cohort Study
Thomas P. Ahern et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2011)
The Hippo pathway in organ size control, tissue regeneration and stem cell self-renewal
Bin Zhao et al.
NATURE CELL BIOLOGY (2011)
Regulation of cancer cell metabolism
Rob A. Cairns et al.
NATURE REVIEWS CANCER (2011)
Targeting protein prenylation for cancer therapy
Norbert Berndt et al.
NATURE REVIEWS CANCER (2011)
Exploiting the mevalonate pathway to distinguish statin-sensitive multiple myeloma
James W. Clendening et al.
BLOOD (2010)
Fluvastatin reduces proliferation and increases apoptosis in women with high grade breast cancer
Elisabeth R. Garwood et al.
BREAST CANCER RESEARCH AND TREATMENT (2010)
Statin Medication Use and the Risk of Biochemical Recurrence After Radical Prostatectomy Results From the Shared Equal Access Regional Cancer Hospital (SEARCH) Database
Robert J. Hamilton et al.
CANCER (2010)
A Transcriptional Signature and Common Gene Networks Link Cancer with Lipid Metabolism and Diverse Human Diseases
Heather A. Hirsch et al.
CANCER CELL (2010)
ABC transporters: lipid transport and inflammation
Timothy J. Sontag et al.
CURRENT OPINION IN LIPIDOLOGY (2010)
Zoledronic acid repolarizes tumour-associated macrophages and inhibits mammary carcinogenesis by targeting the mevalonate pathway
Marta Coscia et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2010)
Dysregulation of the mevalonate pathway promotes transformation
James W. Clendening et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Rb Regulates DNA Damage Response and Cellular Senescence through E2F-Dependent Suppression of N-Ras Isoprenylation
Awad Shamma et al.
CANCER CELL (2009)
Oncogenic KRAS and BRAF Differentially Regulate Hypoxia-inducible Factor-1α and-2α in Colon Cancer
Hirotoshi Kikuchi et al.
CANCER RESEARCH (2009)
A phase II clinical trial does not show that high dose simvastatin has beneficial effect on markers of bone turnover in multiple myeloma
T. E. Sondergaard et al.
HEMATOLOGICAL ONCOLOGY (2009)
A Rac GTPase-Activating Protein, MgcRacGAP, Is a Nuclear Localizing Signal-Containing Nuclear Chaperone in the Activation of STAT Transcription Factors
Toshiyuki Kawashima et al.
MOLECULAR AND CELLULAR BIOLOGY (2009)
Dislocation of HMG-CoA Reductase and Insig-1, Two Polytopic Endoplasmic Reticulum Proteins, En Route to Proteasomal Degradation
Gil S. Leichner et al.
MOLECULAR BIOLOGY OF THE CELL (2009)
Cadherin-Cadherin Engagement Promotes Cell Survival via Rac1/Cdc42 and Signal Transducer and Activator of Transcription-3
Rozanne Arulanandam et al.
MOLECULAR CANCER RESEARCH (2009)
Function of Mitochondrial Stat3 in Cellular Respiration
Joanna Wegrzyn et al.
SCIENCE (2009)
The LKB1-AMPK pathway: metabolism and growth control in tumour suppression
David B. Shackelford et al.
NATURE REVIEWS CANCER (2009)
Androgen levels increase by intratumoral de novo steroidogenesis during progression of castration-resistant prostate cancer
Jennifer A. Locke et al.
CANCER RESEARCH (2008)
Mitochondrial cholesterol contributes to chemotherapy resistance in hepatocellular carcinoma
Joan Montero et al.
CANCER RESEARCH (2008)
Chemoembolization Combined with Pravastatin Improves Survival in Patients with Hepatocellular Carcinoma
Hannah Graf et al.
DIGESTION (2008)
Transcriptional Control of Energy Homeostasis by the Estrogen-Related Receptors
Vincent Giguere
ENDOCRINE REVIEWS (2008)
Statins and cancer: A systematic review and meta-analysis
Jaana Kuoppala et al.
EUROPEAN JOURNAL OF CANCER (2008)
Regulation of HMG-CoA reductase expression by hypoxia
Valentina Pallottini et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2008)
Statin-induced inhibition of 3-hydroxy-3-methyl glutaryl coenzyme A reductase sensitizes human osteosarcoma cells to anticancer drugs
Olivia Fromigue et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2008)
Multiple roles for lipids in the Hedgehog signalling pathway
Suzanne Eaton
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2008)
Bax activation and stress-induced apoptosis delayed by the accumulation of cholesterol in mitochondrial membranes
S. Lucken-Ardjomande et al.
CELL DEATH AND DIFFERENTIATION (2008)
High dose Simvastatin does not reverse resistance to Vincristine, Adriamycin, and Dexamethasone (VAD) in Myeloma
E. van der Spek et al.
HAEMATOLOGICA (2007)
Activation of the PTEN/mTOR/STAT3 pathway in breast cancer stem-like cells is required for viability and maintenance
Jiangbing Zhou et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Inhibition of HMGcoA reductase by atorvastatin prevents and reverses MYC-induced lymphomagenesis
Catherine M. Shachaf et al.
BLOOD (2007)
First clinical experience with simvastatin to overcome drug resistance in refractory multiple myeloma
Ralf Schmidmaier et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2007)
Blockade of adaptive defensive changes in cholesterol uptake and synthesis in AME by the addition of pravastatin to idarubicin plus high-dose Ara-C: a phase 1 study
Steven M. Kornblau et al.
BLOOD (2007)
Determinants of sensitivity to lovastatin-induced apoptosis in multiple myeloma
W. Wei-Lynn Wong et al.
MOLECULAR CANCER THERAPEUTICS (2007)
Statin-induced apoptosis and skeletal myopathy
Amie J. Dirks et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2006)
AMPK and cell proliferation - AMPK as a therapeutic target for atherosclerosis and cancer
Hiroyuki Motoshima et al.
JOURNAL OF PHYSIOLOGY-LONDON (2006)
Statin therapy and autoimmune disease: from protein prenylation to immunomodulation
J Greenwood et al.
NATURE REVIEWS IMMUNOLOGY (2006)
Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins
C Baigent et al.
LANCET (2005)
Transcriptional regulation and transformation by MYC proteins
S Adhikary et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2005)
Choline kinase is a novel oncogene that potentiates RhoA-induced carcinogenesis
A Ramírez de Molina et al.
CANCER RESEARCH (2005)
Statins and the risk of colorectal cancer
JN Poynter et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
A signalling pathway controlling c-Myc degradation that impacts oncogenic transformation of human cells
E Yeh et al.
NATURE CELL BIOLOGY (2004)
Cholesterol synthesis and import contribute to protective cholesterol increments in acute myeloid leukemia cells
DE Banker et al.
BLOOD (2004)
Drug repositioning: Identifying and developing new uses for existing drugs
TT Ashburn et al.
NATURE REVIEWS DRUG DISCOVERY (2004)
AGTPase-activating protein binds STAT3 and is required for IIL-6-induced STAT3 activation and for differentiation of a leukemic cell line
Y Tonozuka et al.
BLOOD (2004)
The AMP-activated protein kinase cascade - a unifying system for energy control
D Carling
TRENDS IN BIOCHEMICAL SCIENCES (2004)
Rheb GTPase is a direct target of TSC2 GAP activity and regulates mTOR signaling
K Inoki et al.
GENES & DEVELOPMENT (2003)
Cholesterol-modulating agents kill acute myeloid leukemia cells and sensitize them to therapeutics by blocking adaptive cholesterol responses
HY Li et al.
BLOOD (2003)
TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling
K Inoki et al.
NATURE CELL BIOLOGY (2002)
HMG-CoA reductase inhibitors and the malignant cell: the statin family of drugs as triggers of tumor-specific apoptosis
WWL Wong et al.
LEUKEMIA (2002)
Simultaneous tyrosine and serine phosphorylation of STAT3 transcription factor is involved in Rho A GTPase oncogenic transformation
S Aznar et al.
MOLECULAR BIOLOGY OF THE CELL (2001)
Rac1 mediates STAT3 activation by autocrine IL-6
TR Faruqi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Regulation of STAT3 by direct binding to the Rac1 GTPase
AR Simon et al.
SCIENCE (2000)
分享论文
